Pharmacology
-
Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
Davies received a Scaling Success grant to advance research on NAPE-PLD activators—potential key players in fighting cardiometabolic diseases. The team’s innovative research could lead to breakthrough treatments. Read MoreMar. 28, 2024
-
Calipari launches AUD Research and Education Center with prestigious $8.9 million NIH grant
An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read MoreMar. 21, 2024
-
Pharmacology’s tradition of academic excellence and mentorship
Sanders-Bush’s legacy ... extends far beyond scientific achievements into mentorship and a commitment to widening the gates of the discipline to welcome scientists of all backgrounds. Read MoreMar. 7, 2024
-
Spotlight: Barrier breakers
By putting one foot in front of another, these trailblazers have changed Vanderbilt—and the world—with their dedication to basic research and breaking down barriers for themselves and others. Read MoreMar. 7, 2024
-
Five Basic Sciences faculty named to Vanderbilt University 2024 endowed chair cohort
Bruce Carter, Lisa Monteggia, Richard O’Brien, Andrea Page-McCaw, and Kevin Schey have been named endowed chairs, the highest academic award that Vanderbilt can give to a faculty member. Read MoreMar. 1, 2024
-
Celebrating recent appointments and promotions in Basic Sciences
We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreJan. 24, 2024
-
Erin Calipari receives $2M to study how alcohol use disorder develops in the brain
Erin Calipari, associate professor of pharmacology and associate director of the Vanderbilt Center for Addiction Research, has received a grant of nearly $2 million from the National Institute on Alcohol Abuse and Alcoholism to understand what happens in the brain that makes… Read MoreSep. 13, 2023
-
Basic Sciences names Hodges, Siciliano as Dean’s Faculty Fellows
By Aaron Conley Emily Hodges, assistant professor of biochemistry, and Cody Siciliano, assistant professor of pharmacology, have been named Dean’s Faculty Fellows of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early… Read MoreAug. 18, 2023
-
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read MoreJul. 6, 2023
-
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read MoreJun. 15, 2023